Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with VBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
VBIO
Valion Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
VBIO
Valion Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
VBIO
Valion Bio, Inc.
Change
0.48
▼
−5.28%
· post 0.50
Closed
Nov 6 '26
Mkt cap
$452,582
Revenue
$146,000
Q3 FY25
Revenue
—
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
VBIO
Valion Bio, Inc.
1,360.90
▼
−0.28%
post 1,358.90
Price
0.48
▼
−5.28%
post 0.50
$1.2T
Mkt cap
$452,582
Q3 FY26
$24.4B
Revenue
$146,000
Q3 FY25
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,360.90
▼
−0.28%
vs
VBIO
0.48
▼
−5.28%
Closed
Nov 6 '26
Co-movers
daily closes
Method
›
Moved together
LLY
with
VBIO
No shared trading history for LLY and VBIO.
Shared co-movers: not yet measured (VBIO).
LLY, solid
VBIO, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes